A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results

被引：0
|
作者：
Brufsky, A. M.
Hoelzer, K. L.
Keaton, M. R.
Beck, J. T.
Krill-Jackson, E.
Wang, Y.
Hu, S.
Vaughn, L. G.
Shonukan, O. O.
机构：
[1] Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA
[2] Springfield Clin, Springfield, IL USA
[3] Accelerated Community Oncol Res Network, Memphis, TN USA
[4] Highlands Oncol Grp, Fayetteville, AR USA
[5] Mt Sinai Med Ctr, Ctr Comprehens Canc, Miami Beach, FL 33140 USA
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Simon Canc Ctr, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1095
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer
    Hoelzer, K. L.
    Brufsky, A.
    Hainsworth, J.
    Beck, J. T.
    Whorf, R.
    Keaton, M.
    Kroener, J.
    Krill-Jackson, E.
    Hu, S.
    Bromund, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer
    Brufsky, Adam
    Hoelzer, Karen
    Beck, Thaddeus
    Whorf, Robert
    Keaton, Mark
    Nadella, Padma
    Krill-Jackson, Elisa
    Kroener, Joan
    Middleman, Edward
    Frontiera, Michael
    Paul, Devchand
    Panella, Timothy
    Bromund, Jane
    Zhao, Luping
    Orlando, Mauro
    Tai, Fritz
    Marciniak, Martin D.
    Obasaju, Coleman
    Hainsworth, John
    [J]. CLINICAL BREAST CANCER, 2011, 11 (04) : 211 - 220
  • [3] INTERIM RESULTS OF A PHASE II STUDY OF NAB-PACLITAXEL, BEVACIZUMAB, AND GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH HER2-NEGATIVE METASTATIC BREAST CANCER (MBC)
    Gluck, S.
    Lobo, C.
    Hurley, J.
    Lopes, G.
    Reis, I.
    Seo, P.
    Silva, O.
    Slingerland, J.
    Welsh, C.
    Tukia, K.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 68 - 69
  • [4] Final results of first-line weekly paclitaxel plus gemcitabine in metastatic breast cancer (MBC): an AERO phase II trial
    Mousseau, M.
    Serin, D.
    Goubely-Brewer, Y.
    Petit, T.
    Priou, F.
    Zelek, L.
    [J]. BULLETIN DU CANCER, 2007, 94 (06) : 569 - 570
  • [5] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial
    Karthaus, Meinolf
    Poddubnaya, Irina
    Churilova, L.
    Khazanov, R.
    Veremeychuk, T.
    Rumyantzeva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, Bernhard
    Heinemann, Volker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer.
    Guardino, A. E.
    Chen, M.
    Levy, M.
    Chen, M.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 853S - 853S
  • [7] Results of first-line weekly paclitaxel (P) plus gemcitabine (G) in metastatic breast cancer (MBC): An AERO phase II trial
    Mousseau, M.
    Serin, D.
    Petit, T.
    Priou, F.
    Zelek, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase II study of nab-paclitaxel, bevacizumab, and gemcitabine for first-line therapy of patients with HER2-negative metastatic breast cancer (MBC)
    Gluck, S.
    Lobo, C.
    Reis, I.
    Lopes, G.
    Carmody, C.
    Tukia, K.
    Hurley, J.
    Seo, P.
    Silva, O.
    Slingerland, J.
    Welsh, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase II study biweekly paclitaxel, doxorubicin and gemcitabine as first line chemotherapy for metastatic breast cancer (MBC).
    Sanchez-Rovira, P
    González, E
    Porras, I
    Jaén, A
    Medina, B
    Fernández, M
    Mohedano, N
    Lozano, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S52 - S52
  • [10] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial.
    Karthaus, M.
    Poddubnaya, I.
    Churilova, L.
    Khasanov, R.
    Veremeychuk, T.
    Rumyantseva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, B.
    Heinemann, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
12345